Antibodies against nerve growth factor (NGF) with enhanced in vivo stability

Details for Australian Patent Application No. 2010244133 (hide)

Owner Abbott Research B.V.

Inventors Powell, John; Maginn, Mark; Casson, Duncan; Best, Andrea; Dutta, Sandeep; Hall, Jerry A.; Liu, Wei

Agent Spruson & Ferguson

Pub. Number AU-A-2010244133

PCT Pub. Number WO2010/128398

Priority 61/238,813 01.09.09 US; 61/175,228 04.05.09 US; 61/227,251 21.07.09 US; 61/252,314 16.10.09 US

Filing date 4 May 2010

Wipo publication date 11 November 2010

International Classifications

C07K 16/22 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

Event Publications

15 December 2011 PCT application entered the National Phase

  PCT publication WO2010/128398 Priority application(s): WO2010/128398

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010244136-Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas

2010244131-Generic assays for detection of influenza viruses